Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 69

1.

High-Dose Rituximab and Early Remission in PLA2R1-Related Membranous Nephropathy.

Seitz-Polski B, Dahan K, Debiec H, Rousseau A, Andreani M, Zaghrini C, Ticchioni M, Rosenthal A, Benzaken S, Bernard G, Lambeau G, Ronco P, Esnault VLM.

Clin J Am Soc Nephrol. 2019 Aug 7;14(8):1173-1182. doi: 10.2215/CJN.11791018. Epub 2019 Jul 24.

PMID:
31340979
2.

Osmotic stress and mortality in elderly patients with kidney failure: a retrospective study.

Grangeon-Chapon C, Dodoi M, Esnault VL, Favre G.

Clin Interv Aging. 2019 Jan 30;14:225-229. doi: 10.2147/CIA.S158987. eCollection 2019.

3.

Longitudinal assessment of renal function in native kidney after bariatric surgery.

Favre G, Schiavo L, Lemoine S, Esnault VLM, Iannelli A.

Surg Obes Relat Dis. 2018 Sep;14(9):1411-1418. doi: 10.1016/j.soard.2018.05.013. Epub 2018 May 24. Review.

PMID:
30077663
4.

Safety of sofosbuvir-based regimens after liver transplantation: longitudinal assessment of renal function in the prospective ANRS CO23 CUPILT study.

Anty R, Favre G, Coilly A, Rossignol E, Houssel-Debry P, Duvoux C, De Ledinghen V, Di Martino V, Leroy V, Radenne S, Kamar N, Canva V, D'Alteroche L, Durand F, Dumortier J, Lebray P, Besch C, Tran A, Canivet CM, Botta-Fridlund D, Montialoux H, Moreno C, Conti F, Silvain C, Perré P, Habersetzer F, Abergel A, Debette-Gratien M, Dharancy S, Esnault VLM, Fougerou-Leurent C, Cagnot C, Diallo A, Veislinger A, Danjou H, Samuel D, Pageaux GP, Duclos-Vallée JC; ANRS CO23 CUPILT Study Group.

Aliment Pharmacol Ther. 2018 Jun;47(12):1682-1689. doi: 10.1111/apt.14639. Epub 2018 Apr 17.

PMID:
29665081
5.

Phospholipase A2 Receptor 1 Epitope Spreading at Baseline Predicts Reduced Likelihood of Remission of Membranous Nephropathy.

Seitz-Polski B, Debiec H, Rousseau A, Dahan K, Zaghrini C, Payré C, Esnault VLM, Lambeau G, Ronco P.

J Am Soc Nephrol. 2018 Feb;29(2):401-408. doi: 10.1681/ASN.2017070734. Epub 2017 Nov 7.

6.

Determinants associated with the correction of glomerular hyper-filtration one year after bariatric surgery.

Favre G, Anty R, Canivet C, Clément G, Ben-Amor I, Tran A, Gugenheim J, Gual P, Esnault VLM, Iannelli A.

Surg Obes Relat Dis. 2017 Oct;13(10):1760-1766. doi: 10.1016/j.soard.2017.07.018. Epub 2017 Jul 19.

PMID:
28869167
7.

Vitamin E-Coated and Heparin-Coated Dialyzer Membranes for Heparin-Free Hemodialysis: A Multicenter, Randomized, Crossover Trial.

Islam MS, Hassan ZA, Chalmin F, Vido S, Berrada M, Verhelst D, Donnadieu P, Moranne O, Esnault VL.

Am J Kidney Dis. 2016 Nov;68(5):752-762. doi: 10.1053/j.ajkd.2016.05.013. Epub 2016 Jun 23.

PMID:
27344212
8.

Epitope Spreading of Autoantibody Response to PLA2R Associates with Poor Prognosis in Membranous Nephropathy.

Seitz-Polski B, Dolla G, Payré C, Girard CA, Polidori J, Zorzi K, Birgy-Barelli E, Jullien P, Courivaud C, Krummel T, Benzaken S, Bernard G, Burtey S, Mariat C, Esnault VL, Lambeau G.

J Am Soc Nephrol. 2016 May;27(5):1517-33. doi: 10.1681/ASN.2014111061. Epub 2015 Nov 13.

9.

Cross-reactivity of anti-PLA2R1 autoantibodies to rabbit and mouse PLA2R1 antigens and development of two novel ELISAs with different diagnostic performances in idiopathic membranous nephropathy.

Seitz-Polski B, Dolla G, Payré C, Tomas NM, Lochouarn M, Jeammet L, Mariat C, Krummel T, Burtey S, Courivaud C, Schlumberger W, Zorzi K, Benzaken S, Bernard G, Esnault VL, Lambeau G.

Biochimie. 2015 Nov;118:104-15. doi: 10.1016/j.biochi.2015.08.007. Epub 2015 Aug 19.

PMID:
26296473
10.

Improvement of Kidney Function Following Bariatric Surgery: Hope or Illusion?

Favre G, Schneck AS, Anty R, Esnault VL, Iannelli A.

Obes Surg. 2015 Oct;25(10):1947-9. doi: 10.1007/s11695-015-1819-z. No abstract available.

PMID:
26220237
11.

Modulation of glucose metabolism by the renin-angiotensin-aldosterone system.

Favre GA, Esnault VL, Van Obberghen E.

Am J Physiol Endocrinol Metab. 2015 Mar 15;308(6):E435-49. doi: 10.1152/ajpendo.00391.2014. Epub 2015 Jan 6. Review.

12.

Constitutive activation of the renin-angiotensin system reduces visceral fat and improves glucose tolerance in mice.

Favre GA, Lebrun P, Lopez P, Butori C, Hofman P, Esnault VL, Van Obberghen E.

J Renin Angiotensin Aldosterone Syst. 2014 Dec;15(4):396-409. doi: 10.1177/1470320314537695. Epub 2014 Nov 4.

PMID:
25371094
13.

Prediction of membranous nephropathy recurrence after transplantation by monitoring of anti-PLA2R1 (M-type phospholipase A2 receptor) autoantibodies: a case series of 15 patients.

Seitz-Polski B, Payré C, Ambrosetti D, Albano L, Cassuto-Viguier E, Berguignat M, Jeribi A, Thouret MC, Bernard G, Benzaken S, Lambeau G, Esnault VL.

Nephrol Dial Transplant. 2014 Dec;29(12):2334-42. doi: 10.1093/ndt/gfu252. Epub 2014 Jul 25.

PMID:
25063424
14.

Determinants and changes associated with aldosterone breakthrough after angiotensin II receptor blockade in patients with type 2 diabetes with overt nephropathy.

Moranne O, Bakris G, Fafin C, Favre G, Pradier C, Esnault VL.

Clin J Am Soc Nephrol. 2013 Oct;8(10):1694-701. doi: 10.2215/CJN.06960712. Epub 2013 Aug 8.

15.

Carbapenem-resistant Klebsiella pneumoniae is associated with poor outcome in hemodialysis patients.

Bleumin D, Cohen MJ, Moranne O, Esnault VL, Benenson S, Paltiel O, Tzukert K, Mor-Yosef Levi I, Ben-Dov IZ, Levi R, Bloch A, Haviv YS.

J Infect. 2012 Oct;65(4):318-25. doi: 10.1016/j.jinf.2012.06.005. Epub 2012 Jun 18.

PMID:
22722020
16.

Diuretic uptitration with half dose combined ACEI + ARB better decreases proteinuria than combined ACEI + ARB uptitration.

Esnault VL, Ekhlas A, Nguyen JM, Moranne O.

Nephrol Dial Transplant. 2010 Jul;25(7):2218-24. doi: 10.1093/ndt/gfp776. Epub 2010 Jan 26.

PMID:
20106824
17.

The effects of amlodipine and enalapril on renal function in adults with hypertension and nondiabetic nephropathies: a 3-year, randomized, multicenter, double-blind, placebo-controlled study.

Esnault VL, Brown EA, Apetrei E, Bagon J, Calvo C, DeChatel R, Holdaas H, Krcmery S, Kobalava Z; Amlodipine Versus Enalapril in Renal failure (AVER) Study Group.

Clin Ther. 2008 Mar;30(3):482-98. doi: 10.1016/j.clinthera.2008.03.006.

PMID:
18405787
18.

What is the value of Tc-99m hydroxymethylene diphosphonate scintigraphy for the etiological diagnosis of mild rhabdomyolysis?

Esnault VL, Nakhla M, Delcroix C, Moutel MG, Couturier O.

Clin Nucl Med. 2007 Jul;32(7):519-23.

PMID:
17581334
19.

An international opinion poll of well-educated people regarding awareness and feelings about organ donation for transplantation.

Cantarovich F, Heguilén R, Filho MA, Duro-Garcia V, Fitzgerald R, Mayrhofer-Reinhartshuber D, Lavitrano ML, Esnault VL.

Transpl Int. 2007 Jun;20(6):512-8. Epub 2007 Mar 9.

20.

[Crescentic glomerulonephritis].

Esnault VL, Moreau A, Testa A, Besnier D.

Nephrol Ther. 2006 Dec;2(7):446-60. Epub 2006 Nov 22. French.

PMID:
17185236
21.

Diuretic and enhanced sodium restriction results in improved antiproteinuric response to RAS blocking agents.

Esnault VL, Ekhlas A, Delcroix C, Moutel MG, Nguyen JM.

J Am Soc Nephrol. 2005 Feb;16(2):474-81. Epub 2004 Dec 22.

22.

High-dose furosemide for established ARF: a prospective, randomized, double-blind, placebo-controlled, multicenter trial.

Cantarovich F, Rangoonwala B, Lorenz H, Verho M, Esnault VL; High-Dose Flurosemide in Acute Renal Failure Study Group.

Am J Kidney Dis. 2004 Sep;44(3):402-9.

PMID:
15332212
23.

Angiotensin-converting-enzyme inhibitors and diuretics for hypertension.

Esnault VL.

N Engl J Med. 2003 Jul 3;349(1):90-3; author reply 90-3. No abstract available.

PMID:
12846229
24.

Difference in antigenic determinant profiles between human and rat myeloperoxidase.

Patry YC, Nachman PH, Audrain MA, Falk RJ, Meflah K, Esnault VL.

Clin Exp Immunol. 2003 Jun;132(3):505-8.

25.

Photopheresis affects the course of experimental allergic encephalomyelitis in Lewis rat.

Chabannes D, Besnier DP, Esnault VL.

Photodermatol Photoimmunol Photomed. 2002 Oct;18(5):238-43.

PMID:
12390665
26.

Apoptosis: the central actor in the three hits that trigger anti-neutrophil cytoplasmic antibody-related systemic vasculitis.

Esnault VL.

Nephrol Dial Transplant. 2002 Oct;17(10):1725-8. Review. No abstract available.

PMID:
12270975
27.
28.

Extracorporeal photochemotherapy for secondary chronic progressive multiple sclerosis: a pilot study.

Besnier DP, Chabannes D, Mussini JM, Dupas B, Esnault VL.

Photodermatol Photoimmunol Photomed. 2002 Feb;18(1):36-41.

PMID:
11982920
29.

[Treatment of vasculitis without antineutrophil cytoplasmic autoantibodies].

Esnault VL.

Presse Med. 2001 Jun 30;30(22):1126-9. Review. French.

PMID:
11484409
30.

[Treatment of vasculitis with antineutrophil cytoplasmic autoantibodies (ACPN)].

Esnault VL.

Presse Med. 2001 Jun 30;30(22):1122-5. Review. French.

PMID:
11484408
31.

[Classification of vasculitis].

Esnault VL.

Presse Med. 2001 Jun 30;30(22):1119-20. Review. French. No abstract available.

PMID:
11484407
32.

Rats injected with syngenic rat apoptotic neutrophils develop antineutrophil cytoplasmic antibodies.

Patry YC, Trewick DC, Gregoire M, Audrain MA, Moreau AM, Muller JY, Meflah K, Esnault VL.

J Am Soc Nephrol. 2001 Aug;12(8):1764-8.

33.

Analysis of anti-neutrophil cytoplasmic antibodies (ANCA): frequency and specificity in a sample of 191 homozygous (PiZZ) alpha1-antitrypsin-deficient subjects.

Audrain MA, Sesboüé R, Baranger TA, Elliott J, Testa A, Martin JP, Lockwood CM, Esnault VL.

Nephrol Dial Transplant. 2001 Jan;16(1):39-44.

PMID:
11208991
34.

[Proteinuria. Diagnostic approach].

Esnault VL.

Rev Prat. 2000 Jun 15;50(12):1383-9. French. No abstract available.

PMID:
10972083
35.

Renoprotective properties of angiotensin-converting enzyme inhibitors: proofs and limits?

Esnault VL.

Nephron. 2000 Jun;85(2):183-4. Review. No abstract available.

PMID:
10867528
36.

Alpha1-antitrypsin phenotypes and anti-neutrophil cytoplasmic auto-antibodies in inflammatory bowel disease.

Taddei C, Audrain MA, Reumaux D, Sesboüe R, Testa A, Galmiche JP, Duthilleul P, Colombel JF, Esnault VL.

Eur J Gastroenterol Hepatol. 1999 Nov;11(11):1293-8.

PMID:
10563543
37.

Effect of protein A immunoadsorption in nephrotic syndrome of various etiologies.

Esnault VL, Besnier D, Testa A, Coville P, Simon P, Subra JF, Audrain MA.

J Am Soc Nephrol. 1999 Sep;10(9):2014-7.

38.

Contamination of commercially purified myeloperoxidase preparations by lactoferrin.

Audrain MA, Reumaux D, Gerson F, Duthilleul P, Wiik A, Muller JY, Esnault VL.

J Immunol Methods. 1999 Jan 1;222(1-2):219-20. No abstract available.

PMID:
10022388
39.

Treatment of graft-versus-host disease by extracorporeal photochemotherapy: a pilot study.

Besnier DP, Chabannes D, Mahé B, Mussini JM, Baranger TA, Muller JY, Milpied N, Esnault VL.

Transplantation. 1997 Jul 15;64(1):49-54.

PMID:
9233700
40.

Antineutrophil cytoplasmic antibodies (ANCA) in chronic graft-versus-host disease after allogeneic bone marrow transplantation.

Martin SJ, Audrain MA, Oksman F, Ecoiffier M, Attal M, Milpied N, Esnault VL.

Bone Marrow Transplant. 1997 Jul;20(1):45-8.

41.
42.
43.

Anti-native and recombinant myeloperoxidase monoclonals and human autoantibodies.

Audrain MA, Baranger TA, Moguilevski N, Martin SJ, Devys A, Lockwood CM, Muller JY, Esnault VL.

Clin Exp Immunol. 1997 Jan;107(1):127-34.

44.

Recurrence of immunoglobulin A nephropathy with immunoglobulin A antineutrophil cytoplasmic antibodies following renal transplantation.

Martin SJ, Audrain MA, Baranger T, Moreau A, Dantal J, Testa A, Esnault VL.

Am J Kidney Dis. 1997 Jan;29(1):125-31. Review.

PMID:
9002541
46.

Anti-neutrophil cytoplasm antibodies in patients with ACR criteria for polyarteritis nodosa: help for systemic vasculitis classification?

Baranger TA, Audrain MA, Testa A, Besnier D, Guillevin L, Esnault VL.

Autoimmunity. 1995;20(1):33-7.

PMID:
7578859
47.

High immunoreactivity of lactoferrin contaminating commercially purified myeloperoxidase.

Audrain MA, Baranger TA, Lockwood CM, Esnault VL.

J Immunol Methods. 1994 Nov 10;176(1):23-31.

PMID:
7963592
48.

[Acute nephritic syndrome. Physiopathology, diagnosis].

Esnault VL.

Rev Prat. 1994 Sep 15;44(14):1971-5. French. No abstract available.

PMID:
7939292
49.

Autoantibodies to lactoferrin and histone in systemic vasculitis identified by anti-myeloperoxidase solid phase assays.

Esnault VL, Short AK, Audrain MA, Jones SJ, Martin SJ, Skehel JM, Lockwood CM.

Kidney Int. 1994 Jul;46(1):153-60.

50.

Absence of antineutrophil cytoplasmic antibodies in giant cell arteritis.

Baranger TA, Audrain MA, Castagne A, Barrier JH, Esnault VL.

J Rheumatol. 1994 May;21(5):871-3.

PMID:
8064728

Supplemental Content

Loading ...
Support Center